Mutation analysis for RUNX1, MLL-PTD, FLT3-ITD, NPM1 and NRAS in 269 patients with MDS or secondary AmL
F Dicker, C Haferlach, J Sundermann, N Wendland… - Leukemia, 2010 - nature.com
F Dicker, C Haferlach, J Sundermann, N Wendland, T Weiss, W Kern, T Haferlach…
Leukemia, 2010•nature.com3 Jabbour E, Kantarjian HM, Abruzzo LV, O'Brien S, Garcia-Manero G, Verstovsek S et al.
Chromosomal abnormalities in Philadelphia chromosome negative metaphases appearing
during imatinib mesylate therapy in patients with newly diagnosed chronic myeloid leukemia
in chronic phase. Blood 2007; 110: 2991–2995. 4 Deininger MW, Cortes J, Paquette R, Park
B, Hochhaus A, Baccarani M et al. The prognosis for patients with chronic myeloid leukemia
who have clonal cytogenetic abnormalities in philadelphia chromosome-negative cells …
Chromosomal abnormalities in Philadelphia chromosome negative metaphases appearing
during imatinib mesylate therapy in patients with newly diagnosed chronic myeloid leukemia
in chronic phase. Blood 2007; 110: 2991–2995. 4 Deininger MW, Cortes J, Paquette R, Park
B, Hochhaus A, Baccarani M et al. The prognosis for patients with chronic myeloid leukemia
who have clonal cytogenetic abnormalities in philadelphia chromosome-negative cells …
3 Jabbour E, Kantarjian HM, Abruzzo LV, O’Brien S, Garcia-Manero G, Verstovsek S et al. Chromosomal abnormalities in Philadelphia chromosome negative metaphases appearing during imatinib mesylate therapy in patients with newly diagnosed chronic myeloid leukemia in chronic phase. Blood 2007; 110: 2991–2995. 4 Deininger MW, Cortes J, Paquette R, Park B, Hochhaus A, Baccarani M et al. The prognosis for patients with chronic myeloid leukemia who have clonal cytogenetic abnormalities in philadelphia chromosome-negative cells. Cancer 2007; 110: 1509–1519.
nature.com